Microsoft word - publikationsliste_priv.-doz. dr. ickenstein_1995-2012

PUBLIKATIONEN
Priv.-Doz. Dr. med. Guntram W. Ickenstein 1995 - 2012
Originalarbeiten:
Muders F, Friedrich E, Luchner A, Pfeifer M, Ickenstein GW, Hamelbeck
B, Riegger G, Elsner D
Hemodynamic changes and neurohumoral regulation during development
of congestive heart failure in a model of epinephrine-induced
cardiomyopathy in conscious rabbits
Muders F, Luchner A, Friedrich E, Ickenstein GW, Riegger G, Elsner D
Modulation of renal blood flow by endogenous endothelin-1 in conscious
rabbits with left ventricular dysfunction
Am. J. Hypertens. 1999, 12, 835 –838
Muders F, Neubauer S, Luchner A, Fredersdorf S, Ickenstein GW,
Riegger GA, Horn M, Elsner D.
Alterations in myocardial creatine kinase (CK) and lactate dehydrogenase
(LDH) isoenzyme-distribution in a model of left ventricular dysfunction
Ickenstein GW, Klotz JM, Langohr HD
Seizures after application of local anesthetics
Dtsch. Zahnärztl. Z 1998 , 5: 337 –339 Ickenstein GW, Klotz JM, Langohr HD
Headache caused by polycythemia vera: Classification of a headache
under the heading of metabolic disturbances
Ickenstein GW, Klotz JM, H.D. Langohr HD
Virusencephalitis with parkinsonism, diabetes insipidus and
panhypopituitarism
Fortschr. Neurol. Psychiat. 1999, 67: 476 - 481 Reuter U, Salomone S, Ickenstein GW, Waeber C.
Effects of chronic sumatriptan and zolmitriptan treatment of 5-HT receptor
expression and function in rats
Cephalgia 2004, 24(5): 398-407
Ickenstein GW, Kelly PJ, Furie KL, Ambrosi D, Rallis N, Goldstein R,
Horick N, Stein J.
Predictors of feeding gastrostomy tube removal in stroke patients with
dysphagia
J Stroke & Cerebrovas Dis 2003, 12 (4): 169-174
Audebert HJ, Kukla C, v. Clarenau C, Kühn J, Schenkel J, Vatankhah B,
Ickenstein GW, Haberl RL, Horn M.
Telemedicine for safe and extended thrombolysis in stroke
Vatankhah B, Dittmar MS, Fehm NP, Erban P, Ickenstein GW, Jakob W,
Bogdahn U, Horn M
Thrombolysis for stroke in the elderly
J Thrombosis Thrombolysis 2005, 20 (1): 25-30 Koch H, Horn M, Bogdahn U, Ickenstein GW
The relationship between plasma D-Dimer concentrations in patients and
acute ischemic stroke subtypes
J Stroke & Cerebrovas Dis 2005, 10 (5): 1-6
Ickenstein GW, Horn M, Schenkel J, Vatankhah B, Bogdahn U, Haberl R,
Audebert HJ.
The use of Telemedicine in combination with a new Stroke-Code-Box
significantly increases t-PA utilization in rural communities
Neurocritical Care 2005, 3: 27-32
Ickenstein GW, Stein J, Ambrosi D, Goldstein R, Horn M, Bogdahn U.
Predictors of survival after severe dysphagic stroke
Ickenstein GW, Goldstein R, Stein J, Henze T, Bogdahn U.
Neuronal regeneration after acute stroke with severe neurogenic
oropharyngeal dysphagia (NOD): a Kaplan-Meier survival analysis
Neurol Rehabil 2005, 11 (5):270-278
Koch HJ, Uyanik G, Bogdahn U, Ickenstein GW
Relation between laterality and immune response after acute cerebral
ischemia
Ickenstein GW, Valaikiene J, Koch H, Hau P, Erban P, Schlachetzki F.
Ultrasonic contrast agents in transcranial perfusion sonography (TPS) for
follow-up of patients with high grade gliomas.
Ickenstein GW, Hennemann B, Sauerbruch S, Luecke K, Haas S, Horn M,
Andreesen R, Bogdahn U, Winkler J.
Mobilization of CD34+ hematopoietic cells, colony-forming cells and long-
term culture-initiating cells into the peripheral blood of patients with an
acute cerebral ischemic insult
Cytotherapy 2008; 3:303-311
Ickenstein GW, Isenmann S, Fiehler J, Gahn G, Schumacher M, Klisch J.
Thrombolysis in neuromedicine: bridging concepts for the management of
acute brain infarction with occlusion of intracranial vessels
Clinical Neuroradiology 2008; 18:88-97
Ickenstein GW.
Brain perfusion assessment with ultrasound contrast-burst imaging for
high-grade gliomas
Imaging & Radiology HIRE 2008; 2:35-36
Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch
Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha
L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V,
Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R,
Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon
BW; PRoFESS Study Group. Aspirin and extended-release dipyridamole
versus clopidogrel for recurrent stroke.
N Engl J Med. 2008; 359:1238-1251
Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch
Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha
L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V,
Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R,
Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon
BW; PRoFESS Study Group. Telmisartan to prevent recurrent stroke and
cardiovascular events. N Engl J Med. 2008; 359:1225-1237
Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch
Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha
L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V,
Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R,
Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon
BW; Prevention Regimen for Effectively Avoiding Second Strokes
(PRoFESS) study group. Effects of aspirin plus extended-release
dipyridamole versus clopidogrel and telmisartan on disability and cognitive
function after recurrent stroke in patients with ischaemic stroke in the
Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS)
trial: a double-blind, active and placebo-controlled study.
Lancet Neurol. 2008;7:875-884.
Ickenstein GW, Hofmayer A, Lindner-Pfleghar B, Pluschinski P, Riecker
A, Schelling A, Prosiegel M. Standardisation of diagnostic and therapeutic
procedures for neurogenic oropharyngeal dysphagia (NOD).
Neurol & Rehabil 2009; 15 (5):290-300 Ickenstein GW, Hofmayer A, Lindner-Pfleghar B, Pluschinski P, Riecker
A, Schelling A, Prosiegel M. Manual for the NOD step-wise concept -
Standardisation of diagnostic and therapeutic procedures for neurogenic
oropharyngeal dysphagia (NOD).
Neurol & Rehabil 2009; 15 (6): 342-354 Teal P, Davis S, Hacke W, Kaste M, Lyden PD; Modified Randomized
Exposure Controlled Trial Study Investigators, Fierus M; Bayer
HealthCare AG. A randomized, double-blind, placebo-controlled trial to
evaluate the efficacy, safety, tolerability, and
pharmacokinetic/pharmacodynamic effects of a targeted exposure of
intravenous repinotan in patients with acute ischemic stroke: modified
Randomized Exposure Controlled Trial (mRECT).
Stroke. 2009; 40:3518-3525
Ickenstein GW, Groß S, Tenckhoff D, Hausn P, Becker U, Klisch J,
Isenmann S. An Empirical Analysis of the Current Need for
Teleneuromedical Care in German Hospitals without Neurology
Departments.
International Journal of Telemedicine Applications 2010;1-10 Dengler R, Diener HC, Schwartz A, Grond M, Schumacher H, Machnig T,
Eschenfelder CC, Leonard J, Weissenborn K, Kastrup A, Haberl R; EARLY
Investigators. Early treatment with aspirin plus extended-release
dipyridamole for transient ischaemic attack or ischaemic stroke within 24
h of symptom onset (EARLY trial): a randomised, open-label, blinded-
endpoint trial. Lancet Neurol. 2010; 9:159-66
Ickenstein GW, Riecker A, Höhlig C, Müller R, Becker U, Reichmann H,
Prosiegel M. Pneumonia and in-hospital mortality in the context of
neurogenic oropharyngeal dyspahgia (NOD) in stroke and a new NOD
step-wise concept. J Neurology 2010; 257:1492-1501
Harrer JU, Valaikiene J, Koch H, Knorr R, Horn M, Ickenstein G, Bogdahn
U, Schlachetzki F. Transcranial perfusion sonography using a low
mechanical index and pulse inversion harmonic imaging: reliability, inter-
/intraobserver variability. Ultraschall Med. 2011; 32:95-101 Ickenstein GW, Höhlig C, Prosiegel M, Koch H, Dziewas R, Bodechtel U,
Müller R, Reichmann H, Riecker A. Prediction of outcome in neurogenic
dysphagia within 72 hours of acute stroke.
J Stroke Cerebrovasc Dis 2011, PMID 21683618 Boy S, Sauerbruch S, Kraemer M, Schormann T, Schlachetzki F, Schuierer
G, Luerding R, Hennemann B, Orso E, Dabringhaus A, Winkler J, Bogdahn
U; RAIS (Regeneration in Acute Ischemic Stroke) Study Group
(Collaborators: Ramm P, Ickenstein GW, Haas S, Horn M, Seidl M, Erban
P, Vatankhah B, Jakob W, Kaiser B, Villarubia V, May RA, Andreesen R,
Schmitz G, Rothe G, Haberl R, Schumacher M, Peschel C). Mobilisation of
hematopoietic CD34+ precursor cells in patients with acute stroke is safe-
-results of an open-labeled non randomized phase I/II trial.
PLoS One. 2011; 6:epub 23099
Theiss S, Günzel F, Storm A, Hausn P, Isenmann S, Klisch J, Ickenstein
GW for the NeuroNet network. Using Routine Data for Quality Assessment
in NeuroNet Telestroke Care. J Stroke Cerebrovasc Dis 2012, PMID
Buchbeiträge:
Ickenstein GW, Jakob W. Hirnödemtherapie:Barbiturate/Hyperventilation
In: Kontroversen in der neurologischen Intensivmedizin. Schneider D,
Schwab S, Hacke W (Hrsg.) Stuttgart New York. Thieme Verlag 2005 (1):
89-95
Ickenstein GW, Audebert H, Wahlgren NG
The implementation of thrombolytic therapy for stroke in routine practice
In: Thrombolytic and Antithrombotic Therapy for Stroke. Hacke W,
Bogousslavsky J (Hrsg.). Informa Healthcare 2006 (15): 167-178 Ickenstein GW, Höhlig C
Pathogenetische Zusammenhänge und moderne Therapieoptionen der
Multiplen Sklerose
In: Multiple Sklerose: Krankheitsbewältigung –Therapiemotivation –Lebensqualität. Twork S, Kugler J (Hrsg.). Springer Verlag 2006 (1): 1-28

Source: http://www.medizin-management-verband.de/pdf/medizin-management-preis-2012/D_HeliosKliniken_Anlage1.pdf